MiniMed (MMED) Cash from Operations (2025 - 2026)
MiniMed (MMED) posted Cash from Operations of -$49.0 million for Q3 2026, up 71.18% quarter-over-quarter from -$170.0 million in Q2 2026, and up 65.25% YoY from -$29.7 million in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) Cash from Operations (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Cash from Operations data on file, last reported at -$49.0 million in Q3 2026.
- For the quarter ending Q3 2026, Cash from Operations rose 65.25% year-over-year to -$49.0 million; the trailing twelve-month figure through Jul 2026 stood at -$277.0 million (changed N/A YoY), and the FY2026 full-year result was -$197.0 million, down 240.71% from the prior year.
- Cash from Operations was -$49.0 million for Q3 2026 at MiniMed, up from -$170.0 million in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of $83.0 million in Q2 2025 to a low of -$170.0 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 367.10 Mn |
| 10 | MiniMed | 6.37 Bn | 6.17 Bn | 465.00 Mn | -49.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -49.00 Mn |
| Apr 24, 2026 | -170.00 Mn |
| Apr 25, 2025 | 83.00 Mn |